Keratoconus

Genetic Factors

• Autosomal inheritance: Autosomal dominant with incomplete penetrance and variable expressivity; autosomal recessive in some families
• Genetic loci: Over 20 chromosomal loci identified; multiple genes involved (complex genetic disorder)
• Gene mutations: VSX1, SOD1, ZEB1, and other genes involved in collagen metabolism and cellular integrity
• Family history: Present in 5-10% of keratoconus patients; variable penetrance makes prediction difficult

Environmental and Mechanical Factors

• Eye rubbing: Major risk factor for progression; mechanical trauma from aggressive or chronic rubbing exacerbates the condition
• Atopic conditions: Strong association with allergic rhinitis, asthma, atopic dermatitis (increased eye rubbing tendency)
• Contact lens wear: Poor-fitting lenses or aggressive insertion/removal technique may accelerate progression

Biochemical and Cellular Abnormalities

• Collagen disturbance: Abnormal collagen structure and cross-linking; altered collagen type ratios
• Oxidative stress: Increased reactive oxygen species; reduced antioxidant defenses
• Protease-antiprotease imbalance: Elevated matrix metalloproteinases; reduced protease inhibitors
• Cellular apoptosis: Enhanced programmed cell death in keratocytes and endothelial cells

Associated Syndromes

• Down syndrome (Trisomy 21): 10-fold higher prevalence; present in 5-10% of Down syndrome individuals
• Ehlers-Danlos syndrome: Connective tissue defect; increased keratoconus prevalence
• Marfan syndrome: Associated with ectopia lentis (not keratoconus); important differential
• Osteogenesis imperfecta: Collagen abnormality predisposes to keratoconus
• Vernal keratoconjunctivitis: Chronic allergic inflammation; mechanical trauma from large papillae

Mechanism of Progressive Ectasia

1. Collagen weakening: Genetically abnormal collagen and disrupted cross-linking reduce corneal rigidity
2. Mechanical stress concentration: Intraocular pressure and external trauma concentrate stress at weakened zones
3. Stromal remodeling: Enhanced protease activity leads to stromal breakdown and thinning
4. Progressive deformation: Cumulative mechanical effects cause focal corneal steepening and cone formation
5. Continued progression: Without intervention, the cycle continues; eye rubbing accelerates progression

Cellular and Molecular Events

• Oxidative stress: Increased ROS production; mitochondrial dysfunction; cellular damage
• Epithelial changes: Thinning; apoptosis; altered tight junctions; reduced barrier function
• Stromal changes: Collagen fibril disorganization; increased protease activity; reduced inhibitors
• Endothelial changes: Cell loss; reduced pump function; secondary corneal edema (advanced stage)

Role of Eye Rubbing

Eye rubbing in genetically predisposed individuals accelerates keratoconus progression through:

• Direct mechanical trauma to weakened stromal tissue
• Increased intraocular pressure during rubbing (particularly with eyelids squeezed)
• Triggering local inflammatory cascade
• Enhanced release of inflammatory mediators and proteases

By Topography and Cone Location

• Central keratoconus: Cone located in central cornea; affects visual axis directly
• Paracentral keratoconus: Cone offset from central axis; may have less visual impact initially
• Pericentral keratoconus: Cone in mid-periphery; indentation pattern visible

By Severity (Amsler-Krumeich Classification)

• Grade I (Mild): Keratometry ≤48D; astigmatism ≤2.0D; minimum thickness ≥400 µm; no scarring
• Grade II (Moderate): Keratometry 48-54D; astigmatism 2.0-6.0D; minimum thickness 300-400 µm; no scarring
• Grade III (Advanced): Keratometry 54-62D; astigmatism 6.0-8.0D; minimum thickness 200-300 µm; possible scarring
• Grade IV (Severe): Keratometry >62D; astigmatism >8.0D; minimum thickness <200 µm; corneal scarring present

ABCD Grading System (Belin-Ambrosio, 2014)

The Belin-Ambrosio ABCD grading system was developed to incorporate Scheimpflug imaging data and provides a parameter-based staging approach that is more sensitive for subclinical disease than Amsler-Krumeich alone. Each parameter is graded independently on a 0–4 scale, yielding a composite profile (e.g., ABCD: 1,2,2,1):

• A — Average Anterior radius of curvature (3 mm zone): Grade 0 (normal) to Grade 4 (severely steep)
• B — Average posterior radius of curvature (3 mm zone): Grade 0 to Grade 4 based on posterior corneal steepening
• C — thinnest pachymetry point: Grade 0 (≥490 µm) to Grade 4 (<200 µm)
• D — Distance best corrected visual acuity (CDVA): Grade 0 (≥20/20) to Grade 4 (<20/400)

Both Amsler-Krumeich and ABCD systems remain in clinical use; ABCD is increasingly favored in modern cornea subspecialty practice for CXL candidacy decisions and subclinical screening.

By Disease Stage

• Subclinical keratoconus: Detected by topography; no clinical signs; often asymptomatic
• Clinical keratoconus: Obvious clinical findings; progressive; symptomatic
• Acute hydrops: Sudden Descemet rupture with corneal edema; severe vision loss
• Scarred keratoconus: End-stage with significant corneal scarring; may require transplantation

Non-Modifiable Risk Factors

• Genetic predisposition; family history of keratoconus
• Age (typically manifests in puberty or early adulthood)
• Down syndrome, Ehlers-Danlos syndrome, osteogenesis imperfecta
• Ethnicity (higher prevalence in certain populations: Middle Eastern, Indian, African)

Modifiable Risk Factors for Progression

• Eye rubbing: Most significant modifiable risk factor; aggressive/chronic rubbing accelerates progression
• Atopic disease: Allergic rhinitis, asthma, atopic dermatitis (associated with eye rubbing)
• Vernal keratoconjunctivitis: Chronic allergic inflammation; mechanical papillary trauma
• Poor contact lens hygiene: Improper fit or insertion/removal technique; chronic irritation
• Prolonged contact lens wear: May increase mechanical stress on cornea

Clinical Signs on Examination

• Cone-shaped cornea: Apex typically central or paracentral; best seen in profile
• Stromal thinning: Localized thinning at cone apex; may be dramatic in advanced cases
• Vertical striae (Vogt lines): Vertical stress lines in anterior stroma visible on slit lamp
• Fleischer ring: Golden-brown hemosiderin ring at cone base; visible with cobalt blue light
• Hazel or brown pigmentation: At the base of the cone (from iron deposition)
• Anterior scarring: Subepithelial scarring; particularly at apex; may progress in advanced disease
• Descemet folds: Fine horizontal folds in Descemet membrane, indicating IOP stress
• Oil droplet reflex: Distorted or irregular light reflex on retinoscopy
• Munson sign: V-shaped bulging of the lower eyelid produced by the ectatic cone when the patient looks downward; a late-stage sign with high specificity for advanced disease
• Rizzuti sign: When a penlight is shone from the temporal limbus, a conical beam of light is focused on the nasal cornea rather than a normal crescent reflex; indicates advanced corneal ectasia

Refractive Signs

• Rapidly changing myopia and astigmatism (frequent refraction changes)
• High irregular astigmatism (more astigmatism on one meridian)
• Asymmetric refractive error between eyes
• Changes in cylinder axis over time

Signs of Acute Hydrops

• Sudden onset of corneal edema (whitening of cone)
• Folds in Descemet membrane (pronounced)
• Rupture of Descemet membrane (visible break)
• Sudden severe vision loss
• Pain and photophobia (secondary epithelial involvement)

Acute Complications

• Acute hydrops: Rupture of Descemet membrane with sudden corneal edema; occurs in 5-10% of keratoconus patients; vision dramatically reduced
• Corneal scarring: From hydrops or chronic mechanical trauma; may be significant and permanent
• Epithelial breakdown: At cone apex; especially during hydrops; risk of infection

Progressive Complications

• Corneal scarring: Progressive anterior subepithelial scarring from inflammation; reduces corneal clarity
• Severe myopia and astigmatism: Progressive refractive error; may become difficult to correct adequately
• Induced astigmatism: Often significant; irregular that cannot be fully corrected with spectacles
• Vision loss: From combination of myopia, astigmatism, irregular astigmatism, scarring, and coma

Contact Lens-Related Complications

• Lens intolerance: Progressive disease and cone apex changes make lens fitting increasingly difficult
• Mechanical trauma from lens: Poor-fitting lenses may accelerate disease progression
• Infection: Contact lens-related infection risk if corneal epithelium compromised

Vision-Threatening Complications

• Corneal perforation: Rare but possible; can occur with hydrops rupture or advanced scarring
• End-stage scars: Extensive scarring requiring corneal transplantation
• Functional blindness: From corneal scars and severe aberrations; may require low vision aids or transplant

Associated Systemic Conditions

• Down syndrome (Trisomy 21): Increased prevalence 10-fold; occurs in 5-10% of individuals with Down syndrome; earlier onset
• Ehlers-Danlos syndrome: Connective tissue disorder; increased keratoconus prevalence; associated with corneal fragility
• Osteogenesis imperfecta: Collagen disorder; increased keratoconus risk
• Marfan syndrome: Associated with ectopia lentis (not keratoconus typically); lens dislocation is key feature
• Atopic diseases: Allergic rhinitis, asthma, atopic dermatitis; associated with eye rubbing behavior
• Vernal keratoconjunctivitis: Chronic allergic inflammation; mechanical trauma from giant papillae
• Ehlers-Danlos and other connective tissue disorders: Systemic collagen abnormalities predispose to corneal ectasia

Allergic/Atopic Manifestations

• Allergic conjunctivitis and rhinitis (often requiring antihistamines)
• Eye rubbing tendency (major accelerating factor for keratoconus progression)
• Vernal keratoconjunctivitis (more severe in some keratoconus patients)

Systemic Metabolic Factors

• Oxidative stress markers: Elevated systemic oxidative stress; reduced antioxidant capacity
• Collagen metabolism abnormalities: Systemic collagen dysregulation may predispose to keratoconus
• Genetic syndromes affecting collagen: Any systemic disorder affecting connective tissue increases risk

Ocular Manifestations of Systemic Diseases

• Lens findings (Marfan): Ectopia lentis (upward); myopia; different from keratoconus
• Posterior staphyloma: In Marfan syndrome (myopia-related, not keratoconus)
• Blue sclerae: In osteogenesis imperfecta; not found in primary keratoconus

Clinical History

• Age of onset and rate of vision change (especially in teens/young adults)
• Family history of keratoconus or genetic disorders
• Associated systemic conditions (Down syndrome, Ehlers-Danlos, etc.)
• Frequent changes in eyeglass prescription
• History of allergy or eye rubbing habits
• Previous contact lens use and tolerance

Slit Lamp Examination

• Visible cone shape (profile view most helpful)
• Fleischer ring (hemosiderin at cone base)
• Vogt lines (vertical stress lines in stroma)
• Anterior scarring at apex
• Descemet folds
• Signs of acute hydrops (if present)

Refraction Assessment

• Rapidly increasing myopia and astigmatism: Especially in young patients
• Irregular astigmatism: More cylinder on one meridian; not uniform
• High refractive error: Often myopia -4.0D to -10.0D or higher; astigmatism frequently >3.0D
• Oil drop reflex: On retinoscopy; indicates optical distortion

Corneal Topography (Definitive Diagnostic Tool)

• Central steepening: Central keratometry >47-48D; marked localized steepening
• Cone identification: Digitally identified cone area; quantified steepness
• Inferior steepening: Asymmetric steepening typically in inferior hemisphere
• Progression monitoring: Serial topography detects rate of change; critical for disease monitoring
• Correlation with severity: Keratometry and asymmetry index correlate with severity classification

Pachymetry (Corneal Thickness)

• Minimum corneal thickness (thinnest point) - important for severity staging
• Helps prognosticate; thinner corneas have worse visual prognosis
• Important before refractive surgery (contraindication if too thin)

Specular Microscopy

• Endothelial cell assessment in advanced disease
• Particularly important if keratoplasty considered
• Can detect endothelial cell loss in advanced keratoconus

Anterior Segment OCT

• High-resolution imaging of corneal architecture
• Detailed visualization of cone, stromal thinning, scarring
• Useful for monitoring progression and detecting early changes

Keratoconus Screening Indices and Topographic Parameters

• Kmax (maximum keratometry): The steepest anterior curvature measurement; >47.2 D is suspicious; >55 D indicates advanced disease; a change of ≥1.0 D over 12 months defines documented progression and is the standard CXL referral trigger
• I-S value (Inferior-Superior asymmetry): Curvature asymmetry between inferior and superior cornea at 3 mm zone; >1.4 D suspicious; >1.9 D highly suggestive of keratoconus
• ISV (Index of Surface Variance): Measures deviation from a sphere across all curvature values; normal <37; keratoconus typically >41
• IVP (Index of Vertical Asymmetry): Measures curvature asymmetry between superior and inferior hemisphere; normal <0.9; keratoconus typically >1.5
• BAD-D (Belin-Ambrosio Deviation index): A composite index on Pentacam incorporating anterior and posterior elevation plus pachymetric progression; score >1.6 has high sensitivity and specificity for keratoconus detection; particularly useful for subclinical cases
• Rapidly changing astigmatism and myopia: In young adults, progression >0.5 D sphere or cylinder per 12 months warrants topographic evaluation regardless of absolute values

General Management and Patient Education

• Avoid eye rubbing: Most critical intervention; aggressive counseling and behavioral modification essential
• Manage allergies: Treat allergic rhinitis, asthma, atopic dermatitis to reduce itch-scratch cycle
• UV protection: Sunglasses with UV protection; may help prevent oxidative stress acceleration
• Regular monitoring: Frequent clinical exams and topography to detect rapid progression
• Genetic counseling: Discuss inheritance pattern with patient and family

Refractive Correction (Mild to Moderate Cases)

• Spectacles: Limited benefit due to irregular astigmatism; over-minusing may help some patients by inducing myopic defocus that masks coma
• Contact lenses (gold standard for most): Rigid gas-permeable (RGP) lenses vault over cone and provide regular refracting surface; significantly improve vision
• Hybrid lenses: RGP center with soft skirt; improved comfort for some patients
• Scleral lenses: Large diameter; saddle-fit over cornea; excellent for advanced disease; improved comfort and stability
• Frequent refraction updates: Prescription may change every 3-6 months in progressive disease

Corneal Cross-Linking (Emerging Therapy)

• Mechanism: UV-A light + riboflavin (vitamin B2) creates cross-links in collagen; strengthens cornea; halts progression
• Indication: Early-to-moderate progressive keratoconus; halts disease progression in 90-95% of cases
• Safety profile: Generally safe; main risk is temporary haze (usually resolves in 3-6 months)
• Success criteria: Corneal minimum thickness >400 µm (to avoid endothelial damage)
• Timing: Earlier intervention (Grade I-II disease) has better outcomes; may prevent need for transplant
• Accelerated CXL protocols: Standard Dresden protocol uses 3 mW/cm² × 30 min (5.4 J/cm² total fluence). Accelerated protocols deliver higher irradiance (9–45 mW/cm²) over shorter duration at equivalent total fluence. Evidence supports ≤9 mW/cm² as having comparable efficacy to the Dresden protocol; protocols >18 mW/cm² may produce reduced stromal demarcation line depth, potentially indicating less effective stromal cross-linking. Epithelium-off (epi-off) remains the evidence standard; transepithelial (epi-on) CXL offers greater patient comfort but shows lower and more variable efficacy and is not recommended as first-line therapy.
• Specialist referral: Consult ophthalmology for cross-linking candidacy and scheduling

Management of Acute Hydrops

• Urgent referral to ophthalmology: Requires specialist evaluation and management
• Hypertonic saline drops/ointment: 5% NaCl to reduce corneal edema
• Topical antibiotics: Prevent infection through epithelial defect
• Contact lens discontinuation: Often required during acute phase
• Therapeutic contact lens: May protect epithelium while edema resolves
• Natural resolution: Most hydrops episodes self-limit over weeks-to-months as edema gradually reabsorbs and Descemet heals

Surgical Interventions (Specialist Referral)

• Corneal transplantation (penetrating keratoplasty or DMEK): Indicated for advanced scarring, steepness >62D, thickness <200 µm, or contact lens failure
• Phototherapeutic keratectomy (PTK): May reduce anterior scarring; limited role
• Intracorneal ring segments: Insert into stromal tunnel to flatten cornea; can improve vision in selected cases

Follow-Up and Monitoring

• Mild disease: Annual examination with topography; education and monitoring
• Moderate disease: Every 3-6 months; consider cross-linking consultation
• Progressive disease: Every 3 months or more frequent; aggressive management and cross-linking referral
• Post-cross-linking: Regular monitoring to confirm halting of progression; may continue slow improvement over time

Disease Progression

• Natural history: Typically rapid progression in teens/20s; slowing by 4th decade; usually stabilizes by age 40
• Rates of progression: Highly variable; some patients have minimal change, others rapid; average progression ~1D/year in active disease
• Factors affecting progression: Eye rubbing (critical), atopic disease, age at onset (earlier=faster), genetic background
• Acute hydrops: Occurs in 5-10% of patients; can occur at any stage; recovery usually occurs over weeks-to-months

Visual Prognosis

• Mild to moderate disease (Grade I-II): Good prognosis for useful vision; contact lenses typically provide adequate correction; cross-linking prevents progression
• Advanced disease (Grade III-IV): More challenging; may require specialty contact lenses (scleral) or surgical intervention
• With cross-linking: Significantly improves prognosis; prevents progression in 90-95%; many avoid need for transplant
• Post-transplantation: Generally good; 80-90% success rates; vision often improves; recurrence rare but possible

Factors Affecting Prognosis

• Favorable: Later age at onset, mild/moderate severity, associated atopy managed, effective eye rubbing cessation, access to cross-linking
• Unfavorable: Early onset, rapid progression, severe disease, atopic disease poorly controlled, continued eye rubbing, Down syndrome/genetic syndrome

Living with Keratoconus

• Psychological impact: Young age at diagnosis; progressive disease; concerns about vision loss; can be significant
• Rehabilitation: Contact lens fitting dramatically improves vision for most; allows near-normal function in many cases
• Work/driving: Visual acuity and glare/aberrations determine fitness; many remain safe drivers with correction
• Quality of life: With modern management (CXL, better lens materials), prognosis significantly improved compared to 10-20 years ago